UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy

Science translational medicine, 2015-10, Vol.7 (310), p.310ra166

2015

Volltextzugriff (PDF)

Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica

Proceedings of the National Academy of Sciences - PNAS, 2011-03, Vol.108 (9), p.3701-3706

2011

Volltextzugriff (PDF)

Mucosal-associated invariant T cells regulate Th1 response in multiple sclerosis

International immunology, 2011-09, Vol.23 (9), p.529-535

2011

Volltextzugriff (PDF)

B-cell depletion therapy for multiple sclerosis

Immunological medicine, 2022-04, Vol.45 (2), p.54-62

2022

Volltextzugriff (PDF)

Disease Exacerbation after the Cessation of Fingolimod Treatment in Japanese Patients with Multiple Sclerosis

Internal Medicine, 2018/09/15, Vol.57(18), pp.2647-2655

2018

Volltextzugriff (PDF)

Association of Smoking and Generalized Manifestations of Myasthenia Gravis

Internal Medicine, 2022/06/01, Vol.61(11), pp.1693-1698

2022

Volltextzugriff (PDF)

B cells in experimental autoimmune encephalomyelitis

Clinical & experimental neuroimmunology, 2021-11, Vol.12 (4), p.213-219

2021

Volltextzugriff (PDF)

Regulatory B cells in neuroimmunological diseases

Clinical & experimental neuroimmunology, 2020-08, Vol.11 (3), p.156-162

2020

Volltextzugriff (PDF)

Cognitive impairment as one of the important non‐motor symptoms in multiple sclerosis and neuromyelitis optica spectrum disorders

Clinical & experimental neuroimmunology, 2019-08, Vol.10 (3), p.152-160

2019

Volltextzugriff (PDF)

Interleukin-6 Immunology in Macrophage Activation Syndrome Related to Neuroimmunological Diseases

Internal Medicine, 2024, pp.3757-24

2024

Volltextzugriff (PDF)

Progressive Multifocal Leukoencephalopathy during Tocilizumab Treatment for Rheumatoid Arthritis

Internal Medicine, 2020/08/15, Vol.59(16), pp.2053-2059

2020

Volltextzugriff (PDF)

Smoking and younger age at onset in anti-acetylcholine receptor antibody-positive myasthenia gravis

Immunological medicine, 2023-06, Vol.46 (2), p.77-83

2023

Volltextzugriff (PDF)

Disease‐modifying drugs for multiple sclerosis in Japan: A focus on the 2017 Japanese guidelines and the 2018 supplement

Clinical & experimental neuroimmunology, 2019-03, Vol.10 (S1), p.49-53

2019

Volltextzugriff (PDF)

Beneficial effects of fingolimod in MS patients with high serum Sema4A levels

PloS one, 2018-03, Vol.13 (3), p.e0193986-e0193986

2018

Volltextzugriff (PDF)

Safety and Effectiveness of Satralizumab in Japanese Patients with Neuromyelitis Optica Spectrum Disorder: A 6-month Interim Analysis of Post-marketing Surveillance

Neurology and therapy, 2024-10, Vol.13 (5), p.1361-1383

2024

Volltextzugriff (PDF)

Fingolimod induces BAFF and expands circulating transitional B cells without activating memory B cells and plasma cells in multiple sclerosis

Clinical immunology (Orlando, Fla.), 2018-02, Vol.187, p.95-101

2018

Volltextzugriff (PDF)

Association of the Processing Speed Test with depression and brain magnetic resonance imaging metrics in Japanese patients with multiple sclerosis

Clinical & experimental neuroimmunology, 2022-11, Vol.13 (4), p.226-233

2022

Volltextzugriff (PDF)

Pilot study on the effects of cognitive behavioral therapy on depression among Japanese patients with multiple sclerosis

Clinical & experimental neuroimmunology, 2019-08, Vol.10 (3), p.180-185

2019

Volltextzugriff (PDF)

Validation of the Brief International Cognitive Assessment for Multiple Sclerosis in Japan

Multiple sclerosis journal - experimental, translational and clinical, 2017-12, Vol.3 (4), p.2055217317748972-2055217317748972

2017

Volltextzugriff (PDF)

B-cell Therapy for Multiple Sclerosis

Brain and nerve = Shinkei kenkyū no shinpo, 2024-10, Vol.76 (10), p.1101

2024

Volltextzugriff (PDF)

Latitude and HLA-DRB1 alleles independently affect the emergence of cerebrospinal fluid IgG abnormality in multiple sclerosis

Multiple sclerosis, 2015-08, Vol.21 (9), p.1112-1120

2015

Volltextzugriff (PDF)

Molecular targeted therapy against B cells in multiple sclerosis

Clinical & experimental neuroimmunology, 2014-12, Vol.5 (s1), p.16-27

2014

Volltextzugriff (PDF)

Relapsing-Remitting Multiple Sclerosis

Brain and nerve = Shinkei kenkyū no shinpo, 2021-05, Vol.73 (5), p.442

2021

Volltextzugriff (PDF)

Cognition with magnetic resonance imaging findings and social activities in patients with multiple sclerosis in a Japanese cohort

Clinical & experimental neuroimmunology, 2019-02, Vol.10 (1), p.41-48

2019

Volltextzugriff (PDF)

Genetic polymorphisms related to vitamin D and the therapeutic potential of vitamin D in multiple sclerosis

Canadian journal of physiology and pharmacology, 2015-05, Vol.93 (5), p.319-325

2015

Volltextzugriff (PDF)

1 – 25 von 107

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(86)
Mit Volltextzugriff
(82)

Publikationsform

Artikel
(106)
Berichte
(1)

Sprache

Englisch
(93)
Japanisch
(14)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy

Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica

Mucosal-associated invariant T cells regulate Th1 response in multiple sclerosis

B-cell depletion therapy for multiple sclerosis

Disease Exacerbation after the Cessation of Fingolimod Treatment in Japanese Patients with Multiple Sclerosis

Association of Smoking and Generalized Manifestations of Myasthenia Gravis

B cells in experimental autoimmune encephalomyelitis

Regulatory B cells in neuroimmunological diseases

Cognitive impairment as one of the important non‐motor symptoms in multiple sclerosis and neuromyelitis optica spectrum disorders

Interleukin-6 Immunology in Macrophage Activation Syndrome Related to Neuroimmunological Diseases

Progressive Multifocal Leukoencephalopathy during Tocilizumab Treatment for Rheumatoid Arthritis

Smoking and younger age at onset in anti-acetylcholine receptor antibody-positive myasthenia gravis

Disease‐modifying drugs for multiple sclerosis in Japan: A focus on the 2017 Japanese guidelines and the 2018 supplement

Beneficial effects of fingolimod in MS patients with high serum Sema4A levels

Safety and Effectiveness of Satralizumab in Japanese Patients with Neuromyelitis Optica Spectrum Disorder: A 6-month Interim Analysis of Post-marketing Surveillance

Fingolimod induces BAFF and expands circulating transitional B cells without activating memory B cells and plasma cells in multiple sclerosis

Association of the Processing Speed Test with depression and brain magnetic resonance imaging metrics in Japanese patients with multiple sclerosis

Pilot study on the effects of cognitive behavioral therapy on depression among Japanese patients with multiple sclerosis

Validation of the Brief International Cognitive Assessment for Multiple Sclerosis in Japan

B-cell Therapy for Multiple Sclerosis

Latitude and HLA-DRB1 alleles independently affect the emergence of cerebrospinal fluid IgG abnormality in multiple sclerosis

Molecular targeted therapy against B cells in multiple sclerosis

Relapsing-Remitting Multiple Sclerosis

Cognition with magnetic resonance imaging findings and social activities in patients with multiple sclerosis in a Japanese cohort

Genetic polymorphisms related to vitamin D and the therapeutic potential of vitamin D in multiple sclerosis

Suchergebnisse filtern